These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 8287570)
21. Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population. Lin DC; Tsai PS; Lin YC Singapore Med J; 2019 Jul; 60(7):359-363. PubMed ID: 30488082 [TBL] [Abstract][Full Text] [Related]
22. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Croughs RJ; Zelissen PM; van Vroonhoven TJ; Hofland LJ; N'Diaye N; Lacroix A; de Herder WW Clin Endocrinol (Oxf); 2000 Feb; 52(2):235-40. PubMed ID: 10671952 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the integrated 3-hour plasma cortisol concentration as a test for Cushing's syndrome. Desai RK; Jialal I; Naidoo C; Omar MA; Joubert SM S Afr Med J; 1987 Feb; 71(3):156-7. PubMed ID: 3810361 [TBL] [Abstract][Full Text] [Related]
24. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. Kennedy L; Atkinson AB; Johnston H; Sheridan B; Hadden DR Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1188-91. PubMed ID: 6437479 [TBL] [Abstract][Full Text] [Related]
25. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. Papanicolaou DA; Mullen N; Kyrou I; Nieman LK J Clin Endocrinol Metab; 2002 Oct; 87(10):4515-21. PubMed ID: 12364428 [TBL] [Abstract][Full Text] [Related]
26. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
27. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385 [TBL] [Abstract][Full Text] [Related]
28. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease. Krieger DT; Allen W J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214 [TBL] [Abstract][Full Text] [Related]
29. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease. Schlechte JA; Sherman B; Pfohl B Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937 [TBL] [Abstract][Full Text] [Related]
30. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome. Stewart PM; Penn R; Gibson R; Holder R; Parton A; Ratcliffe JG; London DR Clin Endocrinol (Oxf); 1992 May; 36(5):453-8. PubMed ID: 1319858 [TBL] [Abstract][Full Text] [Related]
31. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623 [TBL] [Abstract][Full Text] [Related]
32. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome. Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428 [TBL] [Abstract][Full Text] [Related]
33. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810 [TBL] [Abstract][Full Text] [Related]
34. Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness. Malerbi DA; Fragoso MC; Vieira Filho AH; Brenlha EM; Mendonça BB J Clin Endocrinol Metab; 1996 Jun; 81(6):2233-7. PubMed ID: 8964857 [TBL] [Abstract][Full Text] [Related]
35. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome. van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990 [TBL] [Abstract][Full Text] [Related]
36. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism. Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879 [TBL] [Abstract][Full Text] [Related]
37. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours. Cheung NW; Boyages SC Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169 [TBL] [Abstract][Full Text] [Related]
38. Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome. Kirilov G; Tomova A; Dakovska L; Kumanov P; Shinkov A; Alexandrov AS Eur J Endocrinol; 2003 Dec; 149(6):549-53. PubMed ID: 14640996 [TBL] [Abstract][Full Text] [Related]
40. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease. Losa M; Mortini P; Dylgjeri S; Barzaghi R; Franzin A; Mandelli C; Giovanelli M Clin Endocrinol (Oxf); 2001 Jul; 55(1):61-8. PubMed ID: 11453953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]